Clinical Trials Directory

Trials / Unknown

UnknownNCT01121978

Early Vitrectomy for Macular Tractional Maculopathy

Early Vitrectomy for Macular Tractional Maculopathy. Multicenter Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Seoul Retina Investigator Group · Network
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

This study is designed to identify the effect of current vitreous surgery for symptomatic macular tractional maculopathy. Characteristics of this study is as below 1. Multicenter, prospective clinical trial. (early surgical intervention vs.surgical intervention when full-thickness macular hole formation or deterioration of visual acuity occurs) 2. Non-randomized study (decision was made by patients after full explanation) 3. After 1 year follow up, functional change(visual acuity)and anatomical change would be evaluated

Detailed description

Degenerative myopia is relatively common disorder, especially in Korean, Japanese and Chinese. Choroidal neovascularization is well-noted cause of VA deterioration, but nowadays, with improvement of diagnostic tools, such as OCT, VA deterioration from myopic tractional maculopathy is being concerned as well. But till now, the necessity of early vitrectomy on MTM is controversial. By now some clinicians prefer conservative treatment, which means pars plana vitrectomy would be postponed till structural change such as macular hole formation is noticed. And the others prefer early vitrectomy, which means pars plana vitrectomy should be performed when the symptom begins. In this study, investigators try to verify the validity of early vitrectomy comparing conservative treatment.

Conditions

Interventions

TypeNameDescription
PROCEDUREEarly vitrectomyTriamcinolone acetonide assisted pars plana vitrectomy with Indocyanine green dye assisted internal limiting membrane peeling

Timeline

Start date
2009-11-01
Primary completion
2011-11-01
Completion
2012-11-01
First posted
2010-05-12
Last updated
2011-03-29

Locations

10 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01121978. Inclusion in this directory is not an endorsement.